immunoxel, page-6

This announcement was great news and what s/holders like to hear.Sadly it failed to move the SP but it did attract increase turnover and new investors.
It also high lights the difficulty companies have in getting recognition for their hard work and success.Punters,investors have become more selective and astute in where they place their funds and at the same time demand more detail in those announcements.Further more we require regular updates on progress.
My concern at the moment is the inhaler is a desk top model and we dont really have a proto model to sell or demonstrate so how can we sell this on the market place. Lets hope this is quickly rectified.